Pfizer Acquires Immuno-Inflammatory Company Arena for US$6.7 B
By Lucy Haggerty
Pharma Deals Review: Vol 2021 Issue 12 (Table of Contents)
Published: 24 Dec-2021
DOI: 10.3833/pdr.v2021.i12.2651 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Pfizer has agreed to acquire Arena Pharmaceuticals, a clinical stage company focused on the development of therapies for immuno-inflammatory diseases...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS